Citigroup’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $287K | Sell |
14,072
-48,629
| -78% | -$993K | ﹤0.01% | 3189 |
|
2025
Q1 | $1.26M | Buy |
62,701
+21,374
| +52% | +$428K | ﹤0.01% | 2410 |
|
2024
Q4 | $1.1M | Buy |
41,327
+15,748
| +62% | +$420K | ﹤0.01% | 2539 |
|
2024
Q3 | $730K | Sell |
25,579
-42,655
| -63% | -$1.22M | ﹤0.01% | 2769 |
|
2024
Q2 | $1.49M | Buy |
68,234
+61,580
| +925% | +$1.34M | ﹤0.01% | 1969 |
|
2024
Q1 | $147K | Buy |
6,654
+1,069
| +19% | +$23.7K | ﹤0.01% | 3408 |
|
2023
Q4 | $121K | Buy |
5,585
+2,855
| +105% | +$61.6K | ﹤0.01% | 3385 |
|
2023
Q3 | $46.1K | Sell |
2,730
-8,443
| -76% | -$143K | ﹤0.01% | 3477 |
|
2023
Q2 | $153K | Buy |
11,173
+8,427
| +307% | +$116K | ﹤0.01% | 3359 |
|
2023
Q1 | $62.4K | Sell |
2,746
-726
| -21% | -$16.5K | ﹤0.01% | 3566 |
|
2022
Q4 | $81.7K | Sell |
3,472
-83,501
| -96% | -$1.97M | ﹤0.01% | 3413 |
|
2022
Q3 | $2.27M | Sell |
86,973
-45,964
| -35% | -$1.2M | ﹤0.01% | 1521 |
|
2022
Q2 | $2.92M | Buy |
132,937
+124,294
| +1,438% | +$2.73M | ﹤0.01% | 1357 |
|
2022
Q1 | $388K | Sell |
8,643
-5,924
| -41% | -$266K | ﹤0.01% | 3006 |
|
2021
Q4 | $624K | Sell |
14,567
-1,061
| -7% | -$45.5K | ﹤0.01% | 2915 |
|
2021
Q3 | $1.04M | Buy |
15,628
+1,918
| +14% | +$128K | ﹤0.01% | 2363 |
|
2021
Q2 | $1.01M | Buy |
13,710
+11,993
| +698% | +$879K | ﹤0.01% | 2611 |
|
2021
Q1 | $118K | Sell |
1,717
-1,923
| -53% | -$132K | ﹤0.01% | 3626 |
|
2020
Q4 | $244K | Buy |
3,640
+1,778
| +95% | +$119K | ﹤0.01% | 3121 |
|
2020
Q3 | $96K | Sell |
1,862
-2,588
| -58% | -$133K | ﹤0.01% | 3161 |
|
2020
Q2 | $168K | Buy |
4,450
+665
| +18% | +$25.1K | ﹤0.01% | 3170 |
|
2020
Q1 | $113K | Buy |
3,785
+1,707
| +82% | +$51K | ﹤0.01% | 3224 |
|
2019
Q4 | $71K | Buy |
2,078
+1,915
| +1,175% | +$65.4K | ﹤0.01% | 3742 |
|
2019
Q3 | $3K | Buy |
+163
| New | +$3K | ﹤0.01% | 4887 |
|